News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Britannia Life Sciences Announces $5.3 Million Acquisition of Commercial Equipment Loan Portfolio
June 12, 2026
·
5 min read
Press Releases
CORRECTION FROM SOURCE: Entheon Biomedical Corp. Issues Correction to News Release Dated June 9, 2026
June 10, 2026
·
1 min read
Press Releases
Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada
June 10, 2026
·
16 min read
Press Releases
Entheon Announces Change of Directors
June 9, 2026
·
1 min read
Press Releases
Dr. Christina Rahm and The ROOT Brands Celebrate Dual Gold Stevie(R) Awards in New York City
June 9, 2026
·
1 min read
Press Releases
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform
June 9, 2026
·
1 min read
Press Releases
Lifordi Immunotherapeutics Presents Phase 1 Clinical Data for LFD-200, a Subcutaneous Glucocorticoid Antibody Drug Conjugate, at EULAR 2026
June 8, 2026
·
2 min read
Press Releases
OS Therapies Achieves Global Regulatory Alignment on Design of Phase 3 Trial of OST-HER2 in Fully Resected, Pulmonary Metastatic Osteosarcoma
June 8, 2026
·
6 min read
Press Releases
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors
June 8, 2026
·
5 min read
Press Releases
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements
June 4, 2026
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us